Keywords
Perindopril/amlodipine
Blood pressure control
Systolic and diastolic pressure reduction
Submitted : 2024-08-28
Accepted : 2024-09-12
Published : 2024-09-27
Abstract
Objective: To evaluate the efficacy of combination perindopril/amlodipine tablets in patients with high-altitude hypertension who were previously unable to control their blood pressure with monotherapy. Methods: A total of 151 patients with high-altitude hypertension whose blood pressure remained inadequately controlled with previous monotherapy were enrolled in this study. All patients received an 8-week treatment with a combination of perindopril/amlodipine tablets, consisting of perindopril 10 mg/day and amlodipine 5 mg/day. Blood pressure measurements, including both diastolic and systolic pressures, were taken at baseline, and after 2, 4, 6, and 8 weeks of treatment. Results: After 8 weeks of treatment, there was a significant reduction in both average systolic and diastolic blood pressure compared to baseline (P < 0.0001). Specifically, the average systolic blood pressure decreased by 24.45 ± 13.75 mmHg, and the average diastolic blood pressure decreased by 13.37 ± 8.40 mmHg. The overall heart rate showed no significant changes during the treatment period. Conclusion: A combination of perindopril/amlodipine tablets significantly improved blood pressure control in patients with high-altitude hypertension after 8 weeks of treatment. These results support the efficacy of combination perindopril/amlodipine as a viable treatment option for high-altitude hypertension.
References
Ulloa NA, Cook J, 2023, Altitude-Induced Pulmonary Hypertension. StatPearls Publishing, Treasure Island (FL).
Groves BM, Reeves JT, Sutton JR, et al., 1987, Operation Everest II: Elevated High-Altitude Pulmonary Resistance Unresponsive to Oxygen. J Appl Physiol (1985), 63(2): 521–530. https://doi.org/10.1152/jappl.1987.63.2.521
Parati G, Agostoni P, Basnyat B, et al., 2018, Clinical Recommendations for High Altitude Exposure of Individuals with Pre-Existing Cardiovascular Conditions: A Joint Statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine. Eur Heart J, 39(17): 1546–1554. https://doi.org/10.1093/eurheartj/ehx720
Bartsch P, Gibbs JS, 2007, Effect of Altitude on the Heart and the Lungs. Circulation, 116(19): 2191–2202. https://doi.org/10.1161/CIRCULATIONAHA.106.650796
Shroff NA, Balbin J, Shobitan O, 2021, High-Altitude Illness: Updates in Prevention, Identification, and Treatment. Emerg Med Pract, 23(9): 1–24.
Bilo G, Caravita S, Torlasco C, et al., 2019, Blood Pressure at High Altitude: Physiology and Clinical Implications. Kardiol Pol, 77(6): 596–603. https://doi.org/10.33963/KP.14832
Naeije R, 2010, Physiological Adaptation of the Cardiovascular System to High Altitude. Prog Cardiovasc Dis, 52(6): 456–466. https://doi.org/10.1016/j.pcad.2010.03.004
Karpov YA, Gorbunov VM, Deev AD, 2015, Effectiveness of Fixed-Dose Perindopril/Amlodipine on Clinic, Ambulatory and Self-Monitored Blood Pressure and Blood Pressure Variability: An Open-Label, Non Comparative Study in the General Practice. High Blood Press Cardiovasc Prev, 22(4): 417–425. https://doi.org/10.1007/s40292-015-0117-0
Dahlof B, Sever PS, Poulter NR, et al., 2005, Prevention of Cardiovascular Events with An Antihypertensive Regimen of Amlodipine Adding Perindopril as Required versus Atenolol Adding Bendroflumethiazide as Required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A Multicentre Randomised Controlled Trial. Lancet, 366(9489): 895–906. https://doi.org/10.1016/S0140-6736(05)67185-1
Dong J, Cai W, Yue J, et al., 2011, Observation of the Antihypertensive Effect of Amlodipine in Patients with Hypertension in High-Altitude Areas. Journal of Armed Police Medical College, 2011(1): 29–31.